extensive stage small cell lung cancer (SCLC).Methods:We identified patients with SCLC in 2017 using ICD-10 diagnosis (Dx) and drug codes in the 2016-20 Medicare Parts A/B/D 100% Research Identifiable Files. Patients had 1+ lung cancer Dx and continuous enrollment in Parts A/B/D from ...
Naiyer A. Rizvi, MD:I think for limited-stage patients, they’re unlike extensive stage, for whom maintenance was hard to deliver with only a median cycle of 1. I guess for consolidation, they’re unlikely to progress right away, so you’ll actually have time to deliver the drugs. Jami...
Typically, SCLC presents in senior patients (>70 years) with a substantial smoking history. According to historic Veteran’s Administration Lung Study Group staging criteria, SCLC is simply divided into two respective stages: limited stage (LS-SCLC) and extensive stage SCLC (ES-SCLC). Despite ...
Limited (LTD) Stage Small Cell Lung Cancer (SCLC) treated with concurrent BID chest radiotherapy (RT) and etoposide cisplatin (VP/PT) followed by chemotherapy (CT) selected by in vitro Drug Sensitivity Testing (DST)Limited (LTD) Stage Small Cell Lung Cancer (SCLC) treated with concurrent BID...
- 1994 - 173 - www.sciencedirect.comdoi:10.1016/0169-5002(94)94441-5NoneLung Cancer
To evaluate the impact of prophylactic cranial irradiation (PCI) on the prognosis of patients with limited-stage small cell lung cancer (SCLC) in the era of MRI surveillance. Limited-stage SCLC patients with complete remission (CR) or partial remission (
Objective To assess the efficacy and feasibility of chemo-radiotherapy concomitant therapy and 3-dimensional conformal radiotherapy (3DCRT) with limited stage small cell lung cancer (LSCLC).Methods Sixty-five patients with LSCLC were randomly divided into two groups:the treatment group(32 patients)and...
摘要: CODE with G-CSF has shown encouraging outcome in extensive stage SCLC and is highly active in relapsed SCLC. Early administration关键词: peraluminous granites stronlium isotopes inherited zircons oxygen isotopes Caledonian Acadian DOI: 10.1016/S0169-5002(97)89683-3 ...
LBA81 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial doi:10.1016/j.annonc.2024.08.2324Annals of OncologyS. SenanD.R. SpigelB.C. ChoK. ...
1795P Consolidation serplulimab following concurrent hypofractionated chemoradiotherapy for limited-stage SCLC: Preliminary analysis of phase II ASTRUM-LC01 study doi:10.1016/j.annonc.2024.08.1886Annals of OncologyY. WuL. DengJ. WangT. ZhangJ. CaoX. ZhouJ. DuanN. Bi...